In-office testing of hemoglobin A1c levels improves diabetes (type 1 and type 2) decision making¹, diabetic patient compliance², outcomes³ and aides patient management.

Chosen by 3 out of 4 physicians who perform HbA1c testing in their office⁴, the DCA Vantage Analyzer with new version 3.0 software offers additional important benefits:

• Added security access modes with customizable operator access – for up to 1000 operators!
  • Prevent unauthorized users from using the system
  • Definable operator access levels
  • Operator lock-out to protect patient information
  • Audit trail ties patient results to specific operators

• Improved barcode scanning with audible alerts confirms the accuracy of the scan.
  No more guessing if the barcode was scanned - the audible alert clearly and quickly confirms the scan.

• Hemoglobin A1c (HbA1c) reference ranges are provided – this improves results interpretation due to more, comprehensive information
  • Reference ranges are printed, displayed, and transmitted with each patient record
• Control ranges for HbA1c and microalbumin/creatinine tests automatically transmitted
  • Manual logging and errors are reduced
• Estimated Average Glucose (eAG) results are automatically transmitted – improve your result interpretation with more comprehensive information*

• In addition to ASTM, a new POCT1-A2 communication protocol added
  • Standardized two-way communication with data managers
  • When interfaced to third party data management systems (DMS), operator lists can be sent to remote analyzers from a central location
• RAPIDComm-ready** to allow for easy interface to Siemens POC data management system and gain additional capabilities
  
  Note: existing DMS interfaces may need to be updated to support the POCT1-A2 communication protocol

Choose the DCA Vantage Analyzer for your A1c test results

Learn why POC testing of A1c is an important diabetes management tool

*Not available for sale in the U.S.
**In development, not available for sale.

1. Thaler LM, Ziemer DC, Gallina DL, et al. Diabetes in urban Arican-Americans. XVII. Availability of rapid HbA1c measurements enhances clinical decision-making. Diabetes Care. 1999;22:1415-1421.
2. Miller CD, Barned CS, Phillips LS, et al. Rapid A1c availability improves clinical decision-making in an urban primary care clinic. Diabetes Care. 2003;26:1158-1163.
3. Cagliero E, Levina DV, Nathan DM. Immediate feedback of HbA1c levels improves glycemic control in Type 1 and insulin-treated Type 2 diabetic patients. Diabetes Care. 1999;22:1785-1789.
4. GHX Q3 FY2010 Data, HbA1c US Market Data.